BSE Live
Dec 02, 16:01Prev. Close
38.10
Open Price
37.99
Bid Price (Qty.)
38.84 (41)
Offer Price (Qty.)
38.84 (643)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.23 | 2.95 | 3.36 | 3.21 | 0.76 | |
| Diluted EPS (Rs.) | 0.23 | 2.95 | 3.36 | 3.21 | 0.76 | |
| Cash EPS (Rs.) | 9.67 | 9.10 | 8.06 | 6.19 | 3.62 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 98.43 | 98.20 | 95.86 | 93.10 | 89.89 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 98.43 | 98.20 | 95.86 | 93.10 | 89.89 | |
| Dividend / Share(Rs.) | 0.00 | 0.50 | 0.50 | 0.50 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 75.66 | 36.15 | 34.13 | 32.81 | 30.82 | |
| PBDIT/Share (Rs.) | 9.90 | 10.78 | 11.03 | 9.77 | 8.76 | |
| PBIT/Share (Rs.) | 0.46 | 4.63 | 6.32 | 6.80 | 5.90 | |
| PBT/Share (Rs.) | 0.43 | 4.63 | 6.04 | 6.76 | 2.24 | |
| Net Profit/Share (Rs.) | 0.23 | 2.95 | 3.36 | 3.21 | 0.76 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 13.08 | 29.81 | 32.31 | 29.78 | 28.43 | |
| PBIT Margin (%) | 0.60 | 12.80 | 18.52 | 20.71 | 19.14 | |
| PBT Margin (%) | 0.57 | 12.79 | 17.70 | 20.59 | 7.25 | |
| Net Profit Margin (%) | 0.30 | 8.16 | 9.83 | 9.78 | 2.46 | |
| Return on Networth / Equity (%) | 0.23 | 3.00 | 3.50 | 3.44 | 0.84 | |
| Return on Capital Employed (%) | 0.27 | 2.97 | 4.61 | 6.17 | 0.71 | |
| Return on Assets (%) | 0.10 | 1.62 | 2.18 | 2.65 | 0.68 | |
| Total Debt/Equity (X) | 0.52 | 0.39 | 0.24 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.38 | 19.93 | 22.17 | 27.12 | 27.92 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.07 | 2.77 | 3.11 | 4.12 | 8.06 | |
| Quick Ratio (X) | 1.87 | 2.70 | 3.05 | 3.93 | 7.46 | |
| Inventory Turnover Ratio (X) | 4.02 | 20.91 | 36.90 | 16.25 | 11.05 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 15.24 | 11.53 | 13.18 | 11.84 | 5.89 | |
| EV/Net Operating Revenue (X) | 1.29 | 2.04 | 2.47 | 2.31 | 1.22 | |
| EV/EBITDA (X) | 9.84 | 6.83 | 7.63 | 7.74 | 4.30 | |
| MarketCap/Net Operating Revenue (X) | 0.62 | 1.01 | 1.81 | 2.40 | 1.58 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.47 | 0.37 | 0.64 | 0.85 | 0.54 | |
| Price/Net Operating Revenue | 0.62 | 1.01 | 1.81 | 2.40 | 1.58 | |
| Earnings Yield | 0.00 | 0.08 | 0.05 | 0.04 | 0.02 |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y